Occlusion Devices Market by Product (Occlusion Balloon, Stent Retriever, Suction Device, Coil Embolization, Liquid Embolics), Application (Cardiology, Neurology, Peripheral Vascular, Urology, Oncology, Gyno), End User - Global Forecast to 2023
“The occlusion devices market projected to grow at a CAGR of 5.3%.”
The global occlusion devices market is projected to reach USD 3.55 billion by 2023 from USD 2.74 billion in 2018, at a CAGR of 5.3%. Growth in target patient population, technological advancements, favorable reimbursement scenario for minimally invasive surgeries, and the availability of clinical evidence for the safety and efficacy of occlusion procedures are some of the factors responsible for the growth of this market. However, procedural limitations associated with CTO treatments and stringent regulatory frameworks for product commercialization are expected to limit the optimal adoption of occlusion devices during the forecast period.
“The occlusion removal devices segment is poised to be the fastest-growing during the forecast period.”
On the basis of product, the occlusion devices market is segmented into occlusion removal devices (balloon occlusion devices, stent retrievers, coil retrievers, and suction and aspiration devices), embolization devices (embolic coils and liquid embolic agents), tubal occlusion devices, and support catheters (microcatheters and guidewires). The occlusion removal devices segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing number of research studies to evaluate the clinical efficacy of occlusion devices, ongoing technological advancements, and growing availability of innovative occlusion devices across key healthcare markets.
“Asia Pacific is expected to register the highest growth rate during the forecast period.”
Geographically, the occlusion devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC occlusion devices market can be attributed to the rising adoption of occlusion devices due to their decreasing costs (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers) and increasing healthcare expenditure across key APAC countries.
Breakdown of supply-side primary interviews: by company type, designation, and region:
Research Coverage
This report studies the occlusion devices market based on product, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.
Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the occlusion devices market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
The global occlusion devices market is projected to reach USD 3.55 billion by 2023 from USD 2.74 billion in 2018, at a CAGR of 5.3%. Growth in target patient population, technological advancements, favorable reimbursement scenario for minimally invasive surgeries, and the availability of clinical evidence for the safety and efficacy of occlusion procedures are some of the factors responsible for the growth of this market. However, procedural limitations associated with CTO treatments and stringent regulatory frameworks for product commercialization are expected to limit the optimal adoption of occlusion devices during the forecast period.
“The occlusion removal devices segment is poised to be the fastest-growing during the forecast period.”
On the basis of product, the occlusion devices market is segmented into occlusion removal devices (balloon occlusion devices, stent retrievers, coil retrievers, and suction and aspiration devices), embolization devices (embolic coils and liquid embolic agents), tubal occlusion devices, and support catheters (microcatheters and guidewires). The occlusion removal devices segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing number of research studies to evaluate the clinical efficacy of occlusion devices, ongoing technological advancements, and growing availability of innovative occlusion devices across key healthcare markets.
“Asia Pacific is expected to register the highest growth rate during the forecast period.”
Geographically, the occlusion devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC occlusion devices market can be attributed to the rising adoption of occlusion devices due to their decreasing costs (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers) and increasing healthcare expenditure across key APAC countries.
Breakdown of supply-side primary interviews: by company type, designation, and region:
- By Company Type - Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
- By Designation – C-level – 26%, Director-level – 30%, Others – 44%
- By Region – North America - 34%, Europe – 26%, APAC – 23%, RoW – 17%
Research Coverage
This report studies the occlusion devices market based on product, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.
Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the occlusion devices market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the major players in the occlusion devices market. The report analyzes the occlusion devices market based on product, application, end user, and region
- Product Development: Detailed insights on the research and development activities and product launches in the occlusion devices market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various occlusion devices across geographies.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the occlusion devices market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the occlusion devices market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED
1.5 MAJOR MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.2.3 EPIDEMIOLOGY-BASED APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 OCCLUSION DEVICES: MARKET OVERVIEW
4.2 REGIONAL ANALYSIS: OCCLUSION DEVICES MARKET, BY PRODUCT
4.3 REGIONAL ANALYSIS: OCCLUSION DEVICES MARKET, BY END USER (2018)
4.4 ASIA PACIFIC: OCCLUSION DEVICES MARKET, BY APPLICATION,
2018 VS. 2023 (USD MILLION)
4.5 OCCLUSION DEVICES MARKET, BY COUNTRY (2018–2023)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Expansion of target patient population base
5.2.1.2 Technological advancements
5.2.1.3 Favorable reimbursement scenario for minimally invasive surgeries
5.2.1.4 Rising number of minimally invasive vascular surgeries
5.2.1.5 Focus on expansion of manufacturing & distribution capabilities in emerging markets
5.2.1.6 Clinical evidence for safety and efficacy of occlusion devices
5.2.2 RESTRAINTS
5.2.2.1 Procedural limitations associated with CTO treatment
5.2.2.2 Stringent regulatory framework for product commercialization
5.2.3 OPPORTUNITIES
5.2.3.1 Rising healthcare expenditure across developing countries
5.2.4 CHALLENGE
5.2.4.1 Dearth of skilled surgeons
6 OCCLUSION DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 OCCLUSION REMOVAL DEVICES
6.2.1 BALLOON OCCLUSION DEVICES
6.2.2 STENT RETRIEVERS
6.2.3 COIL RETRIEVERS
6.2.4 SUCTION & ASPIRATION DEVICES
6.3 EMBOLIZATION DEVICES
6.3.1 EMBOLIC COILS
6.3.2 LIQUID EMBOLIC AGENTS
6.4 TUBAL OCCLUSION DEVICES
6.5 SUPPORT DEVICES
6.5.1 MICROCATHETERS
6.5.2 GUIDEWIRES
7 OCCLUSION DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CARDIOLOGY
7.3 PERIPHERAL VASCULAR DISEASE
7.4 NEUROLOGY
7.5 UROLOGY
7.6 ONCOLOGY
7.7 GYNECOLOGY
8 OCCLUSION DEVICES MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS, DIAGNOSTIC CENTERS, AND SURGICAL CENTERS
8.3 AMBULATORY CARE CENTERS (ACCS)
8.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
9 OCCLUSION DEVICES MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 GLOBAL MARKET SHARE, BY KEY PLAYERS (2017)
10.3 COMPETITIVE SCENARIO
10.3.1 KEY PRODUCT LAUNCHES AND ENHANCEMENTS
10.3.2 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.3.3 KEY EXPANSIONS
10.3.4 MAJOR MERGERS & ACQUISITIONS
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 INTRODUCTION
11.2 ABBOTT LABORATORIES
11.3 ACROSTAK
11.4 ANGIODYNAMICS
11.5 ASAHI INTECC
11.6 AVINGER
11.7 BOSTON SCIENTIFIC
11.8 B. BRAUN
11.9 CARDINAL HEALTH
11.10 COOK GROUP
11.11 C.R. BARD (A PART OF BECTON DICKINSON)
11.12 EDWARDS LIFESCIENCES
11.13 MEDTRONIC
11.14 PENUMBRA
11.15 STRYKER CORPORATION
11.16 TERUMO CORPORATION
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED
1.5 MAJOR MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.2.3 EPIDEMIOLOGY-BASED APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 OCCLUSION DEVICES: MARKET OVERVIEW
4.2 REGIONAL ANALYSIS: OCCLUSION DEVICES MARKET, BY PRODUCT
4.3 REGIONAL ANALYSIS: OCCLUSION DEVICES MARKET, BY END USER (2018)
4.4 ASIA PACIFIC: OCCLUSION DEVICES MARKET, BY APPLICATION,
2018 VS. 2023 (USD MILLION)
4.5 OCCLUSION DEVICES MARKET, BY COUNTRY (2018–2023)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Expansion of target patient population base
5.2.1.2 Technological advancements
5.2.1.3 Favorable reimbursement scenario for minimally invasive surgeries
5.2.1.4 Rising number of minimally invasive vascular surgeries
5.2.1.5 Focus on expansion of manufacturing & distribution capabilities in emerging markets
5.2.1.6 Clinical evidence for safety and efficacy of occlusion devices
5.2.2 RESTRAINTS
5.2.2.1 Procedural limitations associated with CTO treatment
5.2.2.2 Stringent regulatory framework for product commercialization
5.2.3 OPPORTUNITIES
5.2.3.1 Rising healthcare expenditure across developing countries
5.2.4 CHALLENGE
5.2.4.1 Dearth of skilled surgeons
6 OCCLUSION DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 OCCLUSION REMOVAL DEVICES
6.2.1 BALLOON OCCLUSION DEVICES
6.2.2 STENT RETRIEVERS
6.2.3 COIL RETRIEVERS
6.2.4 SUCTION & ASPIRATION DEVICES
6.3 EMBOLIZATION DEVICES
6.3.1 EMBOLIC COILS
6.3.2 LIQUID EMBOLIC AGENTS
6.4 TUBAL OCCLUSION DEVICES
6.5 SUPPORT DEVICES
6.5.1 MICROCATHETERS
6.5.2 GUIDEWIRES
7 OCCLUSION DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CARDIOLOGY
7.3 PERIPHERAL VASCULAR DISEASE
7.4 NEUROLOGY
7.5 UROLOGY
7.6 ONCOLOGY
7.7 GYNECOLOGY
8 OCCLUSION DEVICES MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS, DIAGNOSTIC CENTERS, AND SURGICAL CENTERS
8.3 AMBULATORY CARE CENTERS (ACCS)
8.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
9 OCCLUSION DEVICES MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 GLOBAL MARKET SHARE, BY KEY PLAYERS (2017)
10.3 COMPETITIVE SCENARIO
10.3.1 KEY PRODUCT LAUNCHES AND ENHANCEMENTS
10.3.2 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.3.3 KEY EXPANSIONS
10.3.4 MAJOR MERGERS & ACQUISITIONS
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 INTRODUCTION
11.2 ABBOTT LABORATORIES
11.3 ACROSTAK
11.4 ANGIODYNAMICS
11.5 ASAHI INTECC
11.6 AVINGER
11.7 BOSTON SCIENTIFIC
11.8 B. BRAUN
11.9 CARDINAL HEALTH
11.10 COOK GROUP
11.11 C.R. BARD (A PART OF BECTON DICKINSON)
11.12 EDWARDS LIFESCIENCES
11.13 MEDTRONIC
11.14 PENUMBRA
11.15 STRYKER CORPORATION
11.16 TERUMO CORPORATION
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 MEDICAL REIMBURSEMENT CODES FOR OCCLUSION-BASED SURGICAL PROCEDURES IN THE US (AS OF DECEMBER 2017)
TABLE 2 OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 3 OCCLUSION DEVICES MARKET FOR OCCLUSION REMOVAL DEVICES, BY TYPE, 2016–2023 (USD MILLION)
TABLE 4 OCCLUSION DEVICES MARKET FOR OCCLUSION REMOVAL DEVICES, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 5 OCCLUSION DEVICES MARKET FOR OCCLUSION REMOVAL DEVICES, BY REGION, 2016–2023 (USD MILLION)
TABLE 6 OCCLUSION DEVICES MARKET FOR BALLOON OCCLUSION DEVICES, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 7 OCCLUSION REMOVAL DEVICES MARKET FOR BALLOON OCCLUSION DEVICES, BY REGION, 2016–2023 (USD MILLION)
TABLE 8 OCCLUSION DEVICES MARKET FOR STENT RETRIEVERS, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 9 OCCLUSION REMOVAL DEVICES MARKET FOR STENT RETRIEVERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 10 OCCLUSION DEVICES MARKET FOR COIL RETRIEVERS, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 11 OCCLUSION REMOVAL DEVICES MARKET FOR COIL RETRIEVERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 12 OCCLUSION DEVICES MARKET FOR SUCTION & ASPIRATION DEVICES, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 13 OCCLUSION REMOVAL DEVICES MARKET FOR SUCTION & ASPIRATION DEVICES, BY REGION, 2016–2023 (USD MILLION)
TABLE 14 OCCLUSION DEVICES MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2016–2023 (USD MILLION)
TABLE 15 OCCLUSION DEVICES MARKET FOR EMBOLIZATION DEVICES, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 16 OCCLUSION DEVICES MARKET FOR EMBOLIZATION DEVICES, BY REGION, 2016–2023 (USD MILLION)
TABLE 17 OCCLUSION DEVICES MARKET FOR EMBOLIC COILS, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 18 EMBOLIZATION DEVICES MARKET FOR EMBOLIC COILS, BY REGION, 2016–2023 (USD MILLION)
TABLE 19 OCCLUSION DEVICES MARKET FOR LIQUID EMBOLIC AGENTS, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 20 EMBOLIZATION DEVICES MARKET FOR LIQUID EMBOLIC AGENTS, BY REGION, 2016–2023 (USD MILLION)
TABLE 21 OCCLUSION DEVICES MARKET FOR TUBAL OCCLUSION DEVICES, BY REGION, 2016–2023 (USD MILLION)
TABLE 22 OCCLUSION DEVICES MARKET FOR SUPPORT DEVICES, BY TYPE, 2016–2023 (USD MILLION)
TABLE 23 OCCLUSION DEVICES MARKET FOR SUPPORT DEVICES, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 24 OCCLUSION DEVICES MARKET FOR SUPPORT DEVICES, BY REGION, 2016–2023 (USD MILLION)
TABLE 25 OCCLUSION DEVICES MARKET FOR MICROCATHETERS, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 26 OCCLUSION DEVICES MARKET FOR MICROCATHETERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 27 OCCLUSION DEVICES MARKET FOR GUIDEWIRES, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 28 OCCLUSION DEVICES MARKET FOR GUIDEWIRES, BY REGION, 2016–2023 (USD MILLION)
TABLE 29 OCCLUSION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 30 OCCLUSION DEVICES MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
TABLE 31 OCCLUSION DEVICES MARKET FOR PERIPHERAL VASCULAR DISEASE, BY REGION, 2016–2023 (USD MILLION)
TABLE 32 OCCLUSION DEVICES MARKET FOR NEUROLOGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
TABLE 33 OCCLUSION DEVICES MARKET FOR UROLOGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
TABLE 34 OCCLUSION DEVICES MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
TABLE 35 OCCLUSION DEVICES MARKET FOR GYNECOLOGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
TABLE 36 OCCLUSION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 37 OCCLUSION DEVICES MARKET FOR HOSPITALS, DIAGNOSTIC CENTERS, AND SURGICAL CENTERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 38 OCCLUSION DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 39 OCCLUSION DEVICES MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2016–2023 (USD MILLION)
TABLE 40 OCCLUSION DEVICES MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 41 NORTH AMERICA: OCCLUSION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 42 NORTH AMERICA: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 43 NORTH AMERICA: OCCLUSION REMOVAL DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 44 NORTH AMERICA: EMBOLIZATION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 45 NORTH AMERICA: SUPPORT DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 46 NORTH AMERICA: OCCLUSION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 47 NORTH AMERICA: OCCLUSION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 48 US: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 49 CANADA: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 50 EUROPE: OCCLUSION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 51 EUROPE: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 52 EUROPE: OCCLUSION REMOVAL DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 53 EUROPE: EMBOLIZATION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 54 EUROPE: SUPPORT DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 55 EUROPE: OCCLUSION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 56 EUROPE: OCCLUSION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 57 GERMANY: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 58 UK: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 59 FRANCE: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 60 ROE: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 61 ASIA PACIFIC: OCCLUSION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 62 ASIA PACIFIC: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 63 ASIA PACIFIC: OCCLUSION REMOVAL DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 64 ASIA PACIFIC: EMBOLIZATION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 65 ASIA PACIFIC: SUPPORT DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 66 ASIA PACIFIC: OCCLUSION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 67 ASIA PACIFIC: OCCLUSION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 68 JAPAN: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 69 CHINA: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 70 INDIA: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 71 ROAPAC: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 72 ROW: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 73 ROW: OCCLUSION REMOVAL DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 74 ROW: EMBOLIZATION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 75 ROW: SUPPORT DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 76 ROW: OCCLUSION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 77 ROW: OCCLUSION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 1 MEDICAL REIMBURSEMENT CODES FOR OCCLUSION-BASED SURGICAL PROCEDURES IN THE US (AS OF DECEMBER 2017)
TABLE 2 OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 3 OCCLUSION DEVICES MARKET FOR OCCLUSION REMOVAL DEVICES, BY TYPE, 2016–2023 (USD MILLION)
TABLE 4 OCCLUSION DEVICES MARKET FOR OCCLUSION REMOVAL DEVICES, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 5 OCCLUSION DEVICES MARKET FOR OCCLUSION REMOVAL DEVICES, BY REGION, 2016–2023 (USD MILLION)
TABLE 6 OCCLUSION DEVICES MARKET FOR BALLOON OCCLUSION DEVICES, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 7 OCCLUSION REMOVAL DEVICES MARKET FOR BALLOON OCCLUSION DEVICES, BY REGION, 2016–2023 (USD MILLION)
TABLE 8 OCCLUSION DEVICES MARKET FOR STENT RETRIEVERS, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 9 OCCLUSION REMOVAL DEVICES MARKET FOR STENT RETRIEVERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 10 OCCLUSION DEVICES MARKET FOR COIL RETRIEVERS, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 11 OCCLUSION REMOVAL DEVICES MARKET FOR COIL RETRIEVERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 12 OCCLUSION DEVICES MARKET FOR SUCTION & ASPIRATION DEVICES, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 13 OCCLUSION REMOVAL DEVICES MARKET FOR SUCTION & ASPIRATION DEVICES, BY REGION, 2016–2023 (USD MILLION)
TABLE 14 OCCLUSION DEVICES MARKET FOR EMBOLIZATION DEVICES, BY TYPE, 2016–2023 (USD MILLION)
TABLE 15 OCCLUSION DEVICES MARKET FOR EMBOLIZATION DEVICES, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 16 OCCLUSION DEVICES MARKET FOR EMBOLIZATION DEVICES, BY REGION, 2016–2023 (USD MILLION)
TABLE 17 OCCLUSION DEVICES MARKET FOR EMBOLIC COILS, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 18 EMBOLIZATION DEVICES MARKET FOR EMBOLIC COILS, BY REGION, 2016–2023 (USD MILLION)
TABLE 19 OCCLUSION DEVICES MARKET FOR LIQUID EMBOLIC AGENTS, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 20 EMBOLIZATION DEVICES MARKET FOR LIQUID EMBOLIC AGENTS, BY REGION, 2016–2023 (USD MILLION)
TABLE 21 OCCLUSION DEVICES MARKET FOR TUBAL OCCLUSION DEVICES, BY REGION, 2016–2023 (USD MILLION)
TABLE 22 OCCLUSION DEVICES MARKET FOR SUPPORT DEVICES, BY TYPE, 2016–2023 (USD MILLION)
TABLE 23 OCCLUSION DEVICES MARKET FOR SUPPORT DEVICES, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 24 OCCLUSION DEVICES MARKET FOR SUPPORT DEVICES, BY REGION, 2016–2023 (USD MILLION)
TABLE 25 OCCLUSION DEVICES MARKET FOR MICROCATHETERS, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 26 OCCLUSION DEVICES MARKET FOR MICROCATHETERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 27 OCCLUSION DEVICES MARKET FOR GUIDEWIRES, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 28 OCCLUSION DEVICES MARKET FOR GUIDEWIRES, BY REGION, 2016–2023 (USD MILLION)
TABLE 29 OCCLUSION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 30 OCCLUSION DEVICES MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
TABLE 31 OCCLUSION DEVICES MARKET FOR PERIPHERAL VASCULAR DISEASE, BY REGION, 2016–2023 (USD MILLION)
TABLE 32 OCCLUSION DEVICES MARKET FOR NEUROLOGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
TABLE 33 OCCLUSION DEVICES MARKET FOR UROLOGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
TABLE 34 OCCLUSION DEVICES MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
TABLE 35 OCCLUSION DEVICES MARKET FOR GYNECOLOGY APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
TABLE 36 OCCLUSION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 37 OCCLUSION DEVICES MARKET FOR HOSPITALS, DIAGNOSTIC CENTERS, AND SURGICAL CENTERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 38 OCCLUSION DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 39 OCCLUSION DEVICES MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2016–2023 (USD MILLION)
TABLE 40 OCCLUSION DEVICES MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 41 NORTH AMERICA: OCCLUSION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 42 NORTH AMERICA: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 43 NORTH AMERICA: OCCLUSION REMOVAL DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 44 NORTH AMERICA: EMBOLIZATION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 45 NORTH AMERICA: SUPPORT DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 46 NORTH AMERICA: OCCLUSION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 47 NORTH AMERICA: OCCLUSION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 48 US: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 49 CANADA: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 50 EUROPE: OCCLUSION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 51 EUROPE: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 52 EUROPE: OCCLUSION REMOVAL DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 53 EUROPE: EMBOLIZATION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 54 EUROPE: SUPPORT DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 55 EUROPE: OCCLUSION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 56 EUROPE: OCCLUSION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 57 GERMANY: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 58 UK: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 59 FRANCE: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 60 ROE: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 61 ASIA PACIFIC: OCCLUSION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 62 ASIA PACIFIC: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 63 ASIA PACIFIC: OCCLUSION REMOVAL DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 64 ASIA PACIFIC: EMBOLIZATION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 65 ASIA PACIFIC: SUPPORT DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 66 ASIA PACIFIC: OCCLUSION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 67 ASIA PACIFIC: OCCLUSION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 68 JAPAN: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 69 CHINA: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 70 INDIA: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 71 ROAPAC: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 72 ROW: OCCLUSION DEVICES MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
TABLE 73 ROW: OCCLUSION REMOVAL DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 74 ROW: EMBOLIZATION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 75 ROW: SUPPORT DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 76 ROW: OCCLUSION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
TABLE 77 ROW: OCCLUSION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN: OCCLUSION DEVICES MARKET
FIGURE 2 BREAKDOWN OF PRIMARIES: OCCLUSION DEVICES MARKET
FIGURE 3 MARKET ESTIMATION: BOTTOM-UP APPROACH
FIGURE 4 MARKET ESTIMATION: TOP-DOWN APPROACH
FIGURE 5 MARKET ESTIMATION: EPIDEMIOLOGY-BASED APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 OCCLUSION REMOVAL DEVICES TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2023
FIGURE 8 NEUROLOGY APPLICATIONS WILL CONTINUE TO DOMINATE THE OCCLUSION DEVICES MARKET IN 2023
FIGURE 9 HOSPITALS, DIAGNOSTIC CENTERS, & SURGICAL CENTERS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE OCCLUSION DEVICES MARKET, 2018
FIGURE 11 RISING HEALTHCARE EXPENDITURE ACROSS DEVELOPING COUNTRIES TO SUPPORT THE GROWTH OF THE OCCLUSION DEVICES MARKET DURING THE FORECAST PERIOD
FIGURE 12 ASIA PACIFIC IS ESTIMATED TO BE THE FASTEST-GROWING MARKET FOR OCCLUSION DEVICES DURING THE FORECAST PERIOD
FIGURE 13 NORTH AMERICA DOMINATED THE OCCLUSION DEVICES MARKET FOR ALL END-USER SEGMENTS IN 2018
FIGURE 14 CARDIOLOGY APPLICATIONS WILL CONTINUE TO DOMINATE THE OCCLUSION DEVICES MARKET IN 2023
FIGURE 15 CHINA & INDIA TO BE THE FASTEST-GROWING COUNTRIES IN THE GLOBAL OCCLUSION DEVICES MARKET
FIGURE 16 OCCLUSION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 17 GERIATRIC POPULATION: BY REGION (2017 VS. 2050)
FIGURE 18 ONGOING CLINICAL RESEARCH PROJECTS IN OCCLUSION DEVICES ACROSS THE GLOBE (AS OF DECEMBER 2017)
FIGURE 19 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES (2011 VS. 2016)
FIGURE 20 OCCLUSION REMOVAL DEVICES TO HOLD LARGEST SHARE OF THE MARKET, BY REGION
FIGURE 21 NEUROLOGY SEGMENT TO DOMINATE THE OCCLUSION DEVICES MARKET BY REGION, 2018
FIGURE 22 HOSPITALS, DIAGNOSTIC CENTERS, AND SURGICAL CENTERS SEGMENT TO DOMINATE THE OCCLUSION DEVICES END-USER MARKET BY REGION, 2018
FIGURE 23 NORTH AMERICA: OCCLUSION DEVICES MARKET SNAPSHOT
FIGURE 24 EUROPE: OCCLUSION DEVICES MARKET SNAPSHOT
FIGURE 25 ASIA PACIFIC: OCCLUSION DEVICES MARKET SNAPSHOT
FIGURE 26 ROW: OCCLUSION DEVICES MARKET SNAPSHOT
FIGURE 27 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE OCCLUSION DEVICES MARKET (2013–2018)
FIGURE 28 BOSTON SCIENTIFIC HELD THE LEADING POSITION IN THE GLOBAL OCCLUSION DEVICES MARKET AS OF 2017
FIGURE 29 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS (2017)
FIGURE 30 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017)
FIGURE 31 ANGIODYNAMICS: COMPANY SNAPSHOT (2017)
FIGURE 32 AVINGER: COMPANY SNAPSHOT (2016)
FIGURE 33 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2017)
FIGURE 34 B. BRAUN: COMPANY SNAPSHOT (2016)
FIGURE 35 CARDINAL HEALTH: COMPANY SNAPSHOT (2017)
FIGURE 36 C.R.BARD: COMPANY SNAPSHOT (2016)
FIGURE 37 EDWARDS LIFESCIENCES: COMPANY SNAPSHOT (2017)
FIGURE 38 MEDTRONIC: COMPANY SNAPSHOT (2017)
FIGURE 39 PENUMBRA: COMPANY SNAPSHOT (2017)
FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT (2017)
FIGURE 41 TERUMO CORPORATION: COMPANY SNAPSHOT (2016)
FIGURE 1 RESEARCH DESIGN: OCCLUSION DEVICES MARKET
FIGURE 2 BREAKDOWN OF PRIMARIES: OCCLUSION DEVICES MARKET
FIGURE 3 MARKET ESTIMATION: BOTTOM-UP APPROACH
FIGURE 4 MARKET ESTIMATION: TOP-DOWN APPROACH
FIGURE 5 MARKET ESTIMATION: EPIDEMIOLOGY-BASED APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 OCCLUSION REMOVAL DEVICES TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2023
FIGURE 8 NEUROLOGY APPLICATIONS WILL CONTINUE TO DOMINATE THE OCCLUSION DEVICES MARKET IN 2023
FIGURE 9 HOSPITALS, DIAGNOSTIC CENTERS, & SURGICAL CENTERS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE OCCLUSION DEVICES MARKET, 2018
FIGURE 11 RISING HEALTHCARE EXPENDITURE ACROSS DEVELOPING COUNTRIES TO SUPPORT THE GROWTH OF THE OCCLUSION DEVICES MARKET DURING THE FORECAST PERIOD
FIGURE 12 ASIA PACIFIC IS ESTIMATED TO BE THE FASTEST-GROWING MARKET FOR OCCLUSION DEVICES DURING THE FORECAST PERIOD
FIGURE 13 NORTH AMERICA DOMINATED THE OCCLUSION DEVICES MARKET FOR ALL END-USER SEGMENTS IN 2018
FIGURE 14 CARDIOLOGY APPLICATIONS WILL CONTINUE TO DOMINATE THE OCCLUSION DEVICES MARKET IN 2023
FIGURE 15 CHINA & INDIA TO BE THE FASTEST-GROWING COUNTRIES IN THE GLOBAL OCCLUSION DEVICES MARKET
FIGURE 16 OCCLUSION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 17 GERIATRIC POPULATION: BY REGION (2017 VS. 2050)
FIGURE 18 ONGOING CLINICAL RESEARCH PROJECTS IN OCCLUSION DEVICES ACROSS THE GLOBE (AS OF DECEMBER 2017)
FIGURE 19 HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES (2011 VS. 2016)
FIGURE 20 OCCLUSION REMOVAL DEVICES TO HOLD LARGEST SHARE OF THE MARKET, BY REGION
FIGURE 21 NEUROLOGY SEGMENT TO DOMINATE THE OCCLUSION DEVICES MARKET BY REGION, 2018
FIGURE 22 HOSPITALS, DIAGNOSTIC CENTERS, AND SURGICAL CENTERS SEGMENT TO DOMINATE THE OCCLUSION DEVICES END-USER MARKET BY REGION, 2018
FIGURE 23 NORTH AMERICA: OCCLUSION DEVICES MARKET SNAPSHOT
FIGURE 24 EUROPE: OCCLUSION DEVICES MARKET SNAPSHOT
FIGURE 25 ASIA PACIFIC: OCCLUSION DEVICES MARKET SNAPSHOT
FIGURE 26 ROW: OCCLUSION DEVICES MARKET SNAPSHOT
FIGURE 27 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE OCCLUSION DEVICES MARKET (2013–2018)
FIGURE 28 BOSTON SCIENTIFIC HELD THE LEADING POSITION IN THE GLOBAL OCCLUSION DEVICES MARKET AS OF 2017
FIGURE 29 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS (2017)
FIGURE 30 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017)
FIGURE 31 ANGIODYNAMICS: COMPANY SNAPSHOT (2017)
FIGURE 32 AVINGER: COMPANY SNAPSHOT (2016)
FIGURE 33 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2017)
FIGURE 34 B. BRAUN: COMPANY SNAPSHOT (2016)
FIGURE 35 CARDINAL HEALTH: COMPANY SNAPSHOT (2017)
FIGURE 36 C.R.BARD: COMPANY SNAPSHOT (2016)
FIGURE 37 EDWARDS LIFESCIENCES: COMPANY SNAPSHOT (2017)
FIGURE 38 MEDTRONIC: COMPANY SNAPSHOT (2017)
FIGURE 39 PENUMBRA: COMPANY SNAPSHOT (2017)
FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT (2017)
FIGURE 41 TERUMO CORPORATION: COMPANY SNAPSHOT (2016)
